GS-5737

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Chronic Obstructive Pulmonary DiseaseCystic Fibrosis

Phase 1

A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects

TerminatedNCT01793649

Gilead SciencesChronic Obstructive Pulmonary Disease, Cystic Fibrosis

Start: 2012-10-31End: 2013-06-30Updated: 2014-03-20

Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF

CompletedNCT01840735

Gilead SciencesCystic Fibrosis

Start: 2013-05-31End: 2013-08-31Updated: 2014-08-12